logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
X

Xin An

College of Plant Protection
H指数:30
被引数:3,293

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial

节拍器卡培他滨作为早期三阴性乳腺癌的延长辅助化疗（SYSUCC-001）：一项随机、III期试验的更新10年结果及事后探索性生物标志物分析

The Lancet Oncology
IF0
2025-11-240
PRE
Jing Yuan; Xi-Wen Bi; Xin Hua; Heng Huang; Li Cai; Li Zhao; Qian-Jun Chen; Xin-Xin Chen; Xu-Lin Wang; Ying Lin; An-Qing Zhang; Yong-Yi Zhong; Fei Xu; Jia-Jia Huang; Xin An; Yan-Xia Shi; Xi Wang; Shu-Sen Wang; Cong Xue; Zhong-Yu Yuan
Retraction notice to “Effect of stakeholder pressure on environmental performance: Do virtual CSR, green credit, environmental and social reputation matter?” [J. Environ. Manag. 368 (2024) 122223]

撤稿通知：“利益相关者压力对环境绩效的影响：虚拟CSR、绿色信贷、环境和社会声誉是否重要？”[J. Environ. Manag. 368 (2024) 122223]

Journal of Environmental Management
IF8.4
2025-11-030
PRE
Muhammad Farrukh Shahzad; Shuo Xu; Xin An; Muhammad Asif; Muhammad Afaq Haider Jafri
Efficacy and Safety of T-DXd in HER2+ and Low/Zero Metastatic BCBM: A Retrospective Multicenter Real-World Study

T-DXd在HER2+和低/零转移性乳腺癌脑转移（BCBM）中的有效性与安全性：一项回顾性多中心真实世界研究

Cancer Science
IF4.3
2025-09-110
OAAI
Qingru Zhou; Yuanyuan Li; Ni He; Guorong Zou; Mengqian Ni; Lulu Zhang; Shu Dun; Zhanhong Chen; Kejun Liu; Yabing Cao; Jiajia Huang; Fei Xu; Zhongyu Yuan; Shusen Wang; Yanxia Shi; Yonggao Mou; Anli Yang; Lixia Li; Xin An
HER2-positive breast cancer with invasive micropapillary carcinoma component shows immunosuppressive microenvironment and resistance to neoadjuvant therapy

HER2阳性伴有浸润性微乳头状癌成分的乳腺癌表现出免疫抑制性微环境和对新辅助治疗的抵抗

Frontiers in Immunology
IF5.9
2025-08-020
OA
Lulu Zhang†; Lijia Zhou†; Anli Yang†; Shaoquan Zheng; Keming Chen; Yutian Zou; Qingru Zhou; Daining Wang; Fei Xu; Jiajia Huang; Zhongyu Yuan; Shusen Wang; Yanxia Shi; Peng Sun; Xin An
Clinical outcome and genomic biomarkers of immune checkpoint inhibitor-based therapies for cancer of unknown primary: a multicenter, real-world study

未分化原发性癌症的免疫检查点抑制剂为基础疗法的临床结果与基因组生物标志物：一项多中心、真实世界研究

Journal of Cancer Research and Clinical Oncology
IF2.8
2025-07-120
OA
Yunjie Huang; Riqing Huang; Meiting Chen; Zhousan Zheng; Haifeng Li; Rishang Chen; Tinghua Gao; Ditian Shu; Anqi Hu; Qiufan Zheng; Xin An; Yanxia Shi; Cong Xue
PD-1/PD-L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First-Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort Study

PD-1/PD-L1抑制剂联合化疗与单用化疗作为不明原因原发灶不良癌症患者的一线治疗方案：一项多中心、回顾性队列研究

MEDCOMM
IF10.7
2025-03-060
OAAI
Huang, Riqing; Li, Haifeng; Li, Shuo; Shu, Ditian; Chen, Rishang; Zheng, Zhousan; Gao, Tinghua; Chen, Meiting; Hu, Anqi; Huang, Yunjie; Zheng, Qiufan; An, Xin; Xue, Cong; Cai, Yuchen
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
breast cancer
IF3.4
2024-04-012
OAAI
Chen, Ying; Li, Wen-Xia; Wu, Jia-Hua; Chen, Geng-Hang; Yang, Chun-Min; Lu, Hai; Wang, Xi; Wang, Shu-Sen; Huang, Heng; Cai, Li; Zhao, Li; Peng, Rou-Jun; Lin, Ying; Tang, Jun; Zeng, Jian; Zhang, Le-Hong; Ke, Yong-Li; Wang, Xian-Ming; Liu, Xin-Mei; Zhang, An-Qin; Xu, Fei; Bi, Xi-Wen; Huang, Jia-Jia; Li, Ji-Bin; Pang, Dan-Mei; Xue, Cong; Shi, Yan-Xia; He, Zhen-Yu; Lin, Huan-Xin; An, Xin; Xia, Wen; Cao, Ye; Guo, Ying; Hong, Ruo-Xi; Jiang, Kui-Kui; Zhong, Yong-Yi; Zhang, Ge; Tienchaiananda, Piyawan; Oikawa, Masahiro; Yuan, Zhong-Yu; Chen, Qian-Jun
A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study
CANCER
IF5.1
2024-03-221
OAAI
Chen, Meiting; Li, Lu; Xia, Qing; Chen, Xiaobing; Liao, Zijun; Wang, Chang; Shen, Bo; Zhou, Min; Zhang, Qingyuan; Zhang, Yanqiao; Qian, Liting; Yuan, Xianglin; Wang, Zhehai; Xue, Cong; An, Xin; Liu, Bin; Gu, Kangsheng; Hou, Mei; Wang, Xiaojia; Wang, Wei; Li, Enxiao; Zhong, Jincai; Cheng, Jing; Shu, Yongqian; Yang, Nong; Wang, Huaqing; Yang, Runxiang; Liu, Tianshu; Deng, Ting; Ma, Fei; Liao, Wangjun; Qiu, Wensheng; Chen, Yu; Chen, Xi; Zhang, Mingzhi; Xu, Ruilian; Li, Xiaoling; Feng, Jifeng; Ba, Yi; Shi, Yanxia

研究方向

暂未获取到该数据
史
史艳侠
H 指数:24论文数:129被引数:2,659
袁
袁中玉
H 指数:28论文数:181被引数:2,970
C
Cong Xue
H 指数:33论文数:239被引数:4,632
M
Meiting Chen
H 指数:18论文数:125被引数:1,370
R
Riqing Huang
H 指数:7论文数:34被引数:241
S
Shusen Wang
H 指数:39论文数:237被引数:6,448
M
Mengqian Ni
H 指数:5论文数:30被引数:121
徐飞 封面图
徐飞
H 指数:33论文数:197被引数:4,097
Q
Qiufan Zheng
H 指数:14论文数:85被引数:838
W
Wen Xia
H 指数:26论文数:130被引数:1,874